Thomas Marron
Clinical trials sponsored by Thomas Marron, explained in plain language.
-
New drug cocktail aims to reawaken immune system against stubborn lung cancer
Disease control OngoingThis trial is testing a new three-drug combination for people with advanced non-small cell lung cancer that has spread and stopped responding to standard immunotherapy. The study aims to see if adding two drugs (dupilumab and anakinra) to a common immunotherapy can make it work a…
Phase: PHASE1, PHASE2 • Sponsor: Thomas Marron • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Old HIV drug gets new shot at fighting stubborn cancers
Disease control OngoingThis early-stage trial is testing whether adding lamivudine, a drug typically used for HIV, can help restart the effectiveness of immunotherapy in patients with advanced solid tumors that have stopped responding. The study will enroll 6-24 patients at Mount Sinai to first check s…
Phase: PHASE1, PHASE2 • Sponsor: Thomas Marron • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC